Mesoblast Ltd. (MESO)
18.18
+1.34
(+7.93%)
USD |
NASDAQ |
Aug 27, 16:00
18.18
0.00 (0.00%)
After-Hours: 19:27
Mesoblast Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 501.84M |
| March 31, 2023 | 482.17M |
| December 31, 2022 | 500.00M |
| September 30, 2022 | 522.81M |
| June 30, 2022 | 497.04M |
| March 31, 2022 | 517.13M |
| December 31, 2021 | 535.51M |
| September 30, 2021 | 559.75M |
| June 30, 2021 | 581.40M |
| March 31, 2021 | 600.93M |
| December 31, 2020 | 518.73M |
| September 30, 2020 | 538.51M |
| June 30, 2020 | 549.33M |
| March 31, 2020 | 487.81M |
| December 31, 2019 | 500.80M |
| September 30, 2019 | 475.15M |
| Date | Value |
|---|---|
| June 30, 2019 | 481.05M |
| March 31, 2019 | 500.94M |
| December 31, 2018 | 524.56M |
| September 30, 2018 | 527.60M |
| June 30, 2018 | 546.01M |
| March 31, 2018 | 556.14M |
| December 31, 2017 | 575.60M |
| September 30, 2017 | 559.59M |
| June 30, 2017 | 516.77M |
| March 31, 2017 | 540.40M |
| December 31, 2016 | 510.52M |
| September 30, 2016 | 509.87M |
| June 30, 2016 | 528.16M |
| March 31, 2016 | 478.94M |
| December 31, 2015 | 492.75M |
| September 30, 2015 | 452.83M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | 9.828M |
| Actinogen Medical Ltd. | -- |